Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jianhua Mao, PhD
CONTACT
Qiuyu Li, MD
CONTACT
Lead
The Children's Hospital of Zhejiang University School of Medicine
This is an investigator-initiated trial to evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in Patients With B cell mediated autoimmune disease. Study intervention consists of a single infusion of universal allogeneic CART-cells administered intravenously after a lymphodepleting therapy regimen consisting of cyclophosphamide. Interim analysis will be performed when participants finish the visit 12 and 24 weeks after CART-cell infusion.
Age
3–any
Sex
ALL
Healthy volunteers
Not accepted